Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma

Volume: 39, Issue: 5, Pages: 1369 - 1376
Published: Jan 1, 2021
Abstract
The treatment landscape for renal cell carcinoma (RCC) is rapidly evolving. The aim of this review is to summarize the randomized-controlled trials evaluating the role of immunotherapy in neoadjuvant or adjuvant setting. We searched PubMed, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for studies including neoadjuvant or adjuvant immunotherapy, and provided a brief overview of the pharmacodynamics of immunotherapy for...
Paper Details
Title
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma
Published Date
Jan 1, 2021
Volume
39
Issue
5
Pages
1369 - 1376
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.